Ribogenics
Philadelphia, US · Founded 2018 · Delaware corporation
Founders & leadership
WZ
Wei ZhangNamed on SEC filing
YR
Yves RibeillNamed on SEC filing
LA
Laurent ArthaudNamed on SEC filing
SB
Serge BraunNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$6M disclosed across 1 round · 2021
▶$6MraisedFeb 2021 · 3 investors · BiotechnologyRule 506(b)
▶$6MraisedFeb 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wei ZhangDirector
- Yves RibeillExecutive Officer
- Laurent ArthaudDirector
- Serge BraunDirector
- Offering amount
- $8M
- Amount sold
- $6M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Ribogenics raised?
- Ribogenics has disclosed $6M raised across 1 round.
- Where is Ribogenics headquartered?
- Ribogenics is headquartered in Philadelphia, US.